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The hippocampus is prone to epileptic seizures and is a key brain region and
experimental platform for investigating mechanisms associated with the abnormal
neuronal excitability that characterizes a seizure. Accordingly, the hippocampal slice
is a common in vitro model to study treatments that may prevent or reduce seizure
activity. The ketogenic diet is a metabolic therapy used to treat epilepsy in adults
and children for nearly 100 years; it can reduce or eliminate even severe or refractory
seizures. New insights into its underlying mechanisms have been revealed by diverse
types of electrophysiological recordings in hippocampal slices. Here we review these
reports and their relevant mechanistic findings. We acknowledge that a major difficulty
in using hippocampal slices is the inability to reproduce precisely the in vivo condition
of ketogenic diet feeding in any in vitro preparation, and progress has been made in
this in vivo/in vitro transition. Thus far at least three different approaches are reported to
reproduce relevant diet effects in the hippocampal slices: (1) direct application of ketone
bodies; (2) mimicking the ketogenic diet condition during a whole-cell patch-clamp
technique; and (3) reduced glucose incubation of hippocampal slices from ketogenic
diet–fed animals. Significant results have been found with each of these methods
and provide options for further study into short- and long-term mechanisms including
Adenosine triphosphate (ATP)-sensitive potassium (KATP) channels, vesicular glutamate
transporter (VGLUT), pannexin channels and adenosine receptors underlying ketogenic
diet and other forms of metabolic therapy.
Keywords: ketone bodies, adenosine receptors, pannexin channels, ATP-sensitive potassium channels, vesicular
glutamate transporter, temporal lobe epilepsy
HIPPOCAMPUS: A KEY BRAIN REGION TO INVESTIGATE
KETOGENIC DIET MECHANISMS
The hippocampus is well-known as a brain area involved in learning and memory and also as the
key region underlying the form of epilepsy known as mesial temporal lobe epilepsy. The temporal
lobe refers to the ventrolateral middle part of cerebral cortex and abnormal neuronal discharge or
a lesion affecting this lobe causes seizures (Gastaut, 1973). There are two main types of temporal
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lobe epilepsy classified by the epileptic focus: mesial and lateral.
The epileptic focus of mesial temporal lobe epilepsy is the
hippocampus, amygdala or parahippocampal gyrus and the
focus of lateral temporal lobe epilepsy is in neocortex. Over
80% of patients with temporal lobe epilepsy have the mesial
form (Schramm et al., 2001; Quarato et al., 2005) and it
is often resistant to pharmacological treatment. The typical
symptom of mesial temporal lobe epilepsy is complex partial
seizures, which have a high probability of an accompanying
characteristic aura. For an individual patient the aura may
present as epigastric discomfort sometimes described as nausea,
or psychiatric symptoms including fear. Complex partial seizures
often begin with arrest of motor activities or staring. Autonomic
motor behaviors are usually oroalimentary automatisms or
complex automatisms. Dystonic posturing lasting for 1–2 min
often occurs involving the arm contralateral to the ictal discharge
(Engel, 2001). In a majority of patients, mesial temporal lobe
epilepsies are associated with hippocampal sclerosis (Watson,
2003), which is atrophy with global gliosis and loss of CA1 and/or
CA3 pyramidal neurons in the hippocampus (Thom, 2009).
The basic structure of hippocampus is simple. It includes
principal cells (granular cells of dentate gyrus and CA1-4
pyramidal neurons) and surrounding interneurons. The
principal cells form an excitatory circuit which is modulated
by inhibitory interneurons. Notably, CA3 pyramidal neurons
are connected to each other by excitatory recurrent collaterals.
Thus, the hippocampal circuit is regulated by a balance between
excitation from recurrent collaterals and inhibition from
interneurons. When the balance collapses, the hippocampal
circuit becomes hyper excitable and susceptible to seizures.
Therefore, atrophy in the hippocampus is thought to be one of
the main focuses of mesial temporal lobe epilepsy and excision of
hippocampal sclerosis with selective amygdalohippocampectomy
successfully improves ∼70% of surgical patients (Wiebe et al.,
2001; Paglioli et al., 2006). Unfortunately, even though a majority
experience significant improvement after surgery, at least half of
patients relapse and do not experience permanent and complete
seizure control (McIntosh et al., 2004; de Tisi et al., 2011; Najm
et al., 2013). Based on clinical and experimental evidence, the
hippocampus is a good experimental target for investigating
epileptogenesis and therapeutic interventions for temporal lobe
epilepsy.
The ketogenic diet was designed in the 1920s to treat
epilepsy by mimicking the metabolic changes induced by
fasting (Wilder, 1921). Ketogenic diet is effective against
many types of seizures. It is used more frequently against
generalized seizures such as myoclonic, atonic and absence
seizures. However, it is also reported that ketogenic diet has
been used successfully to treat focal seizures such as simple and
complex partial seizures as effectively as generalized seizures
[Freeman et al., 1998; Maydell et al., 2001; but one study
reported that the ketogenic diet was less effective in patients
with epileptiform discharges in the temporal region (Beniczky
et al., 2010)]. Despite almost 100 years of clinical use, however,
the mechanisms underlying the success of ketogenic diet
therapy are not well understood. In recent decades, ketogenic
diet has increasingly been noted as a useful therapy for
medically refractory epilepsy in adults (Sirven et al., 1999;
Mosek et al., 2009) and children (Hallböök et al., 2007).
Patients with temporal lobe epilepsy are well-known to be
frequently resistant to antiepileptic drugs (Wiebe and Jette,
2012). As mentioned above, the first choice of treatment for
medically refractory mesial temporal lobe epilepsy associated
with hippocampal sclerosis is surgery (anterior temporal
lobectomy or selective amygdalohippocampectomy) because
of good therapeutic outcomes (Tanriverdi et al., 2008). For
temporal lobe epilepsy patients who are not good candidates
for surgery, however, ketogenic diet is one of the therapeutic
options (Ray and Wyllie, 2005; Klein et al., 2010). Thus, a
natural question is how the ketogenic diet produces its beneficial
effects in temporal lobe epilepsy. Broad reviews on the diet’s
mechanisms are available (Lutas and Yellen, 2013; Rogawski
et al., 2016); here, we focus on work from multiple laboratories
studying ketogenic diet’s antiseizure mechanisms using acute
hippocampal slice preparations.
ADVANTAGES OF THE HIPPOCAMPAL
SLICE PREPARATION IN STUDYING
ANTIEPILEPTIC MECHANISMS OF
KETOGENIC DIET
Because epilepsy is caused by abnormal neuronal discharges
in the brain, electrophysiological measurements are the most
direct and useful approach for researching epilepsy and its
treatments. There are two approaches for electrophysiological
recordings of any brain region: in vivo and in vitro. In vivo
electrophysiological recording of hippocampus is usually done
by extracellular recording of electrically-evoked activity (Stewart
and Reid, 1993), or continuous recording of spontaneous
field activity (Li et al., 2008), single-cell intracellular sharp
electrodes (Henze and Buzsáki, 2001) or multiple unit activity
(Lin et al., 2006); these preparations can be acute or
chronic. The technique for in vivo patch-clamp recording was
also developed recently (Pernia-Andrade and Jonas, 2014).
In vitro electrophysiological recording is done using single-cell
intracellular sharp electrodes (Abe and Ogata, 1981) or
patch-clamp electrodes (Kawamura et al., 2004), or extracellular
field recording with single electrodes (Masino and Dunwiddie,
1999) or electrode arrays (Knowles et al., 1987) using acute
slices of hippocampus. Compared with in vivo hippocampal
recordings, the advantages of hippocampal slices are several-
fold: (1) Ease of use and tissue access: acute brain slices
must be maintained by perfusion with oxygenated artificial
cerebrospinal fluid (Sakmann et al., 1989). Continuous perfusion
allows for changing the extracellular fluid, making it easy to
apply and wash out agonists and/or antagonists of various
proteins such as ion channels, receptors and transporters.
Furthermore, it is easy to examine in detail the functional
mechanisms and dynamics of neuronal activity; (2) Efficient
use of resources: we usually make 3–6 brain slices from one
rodent, potentially obtaining 3–6 recordings, and thus allowing
us to reduce the number of animals used; (3) History: a huge
number of electrophysiological experiments have been done
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using hippocampal slice preparations in the last half-century.
Several methods for causing seizure-like bursting in vitro have
been used in the hippocampal slice preparation including
electrical kindling (Sayin et al., 1999), kainic acid treatment
(Congar et al., 2000; Smith and Dudek, 2001), inhibition of
GABA receptors (Köhling et al., 2000; Stafstrom et al., 2009),
inhibition of potassium ion channels (Stafstrom et al., 2009)
and neuronal hyperexcitability by high extracellular potassium
concentrations (Congar et al., 2000; Stafstrom et al., 2009)
or low extracellular magnesium concentrations (Dulla et al.,
2005; Kovács et al., 2005); and (4) Potential use of human
tissue: experimental techniques from rodent hippocampal slice
preparations are also applicable to acutely resected hippocampal
tissue obtained from patients with surgically approachable
epilepsy (Schroder et al., 2000). All these approaches support
the use of hippocampal slice preparations to elucidate epileptic
mechanisms.
Among these advantages lurk some disadvantages. One
unavoidable pitfall of in vitro recording is that the environment
of acute brain slice preparations is inherently different
from in vivo condition. Cutting brain tissue causes acute
traumatic injury such as excitatory GABA signaling caused
by increased intracellular chloride concentration in acute
hippocampal preparations (Dzhala et al., 2012). It is known
that gliosis occurs in the hippocampal slice cultures (Lossi
et al., 2009). Recently, it has been reported that the early
stage of reactive gliosis already occurs in acute hippocampal
slice preparations (Takano et al., 2014). We usually cut slices
at 300–500 µm, necessarily limiting neuronal networks and
three-dimensional morphologies to this thickness. Also,
artificial cerebrospinal fluid does not and cannot reproduce
actual cerebrospinal fluid exactly. Thus, results from in vitro
hippocampal slice preparations should be confirmed by
in vivo electrophysiological recordings or behavioral tests as
much as possible. For that reason both in vivo and in vitro
electrophysiological recordings are useful and both are essential
for epilepsy research.
Ketogenic diet therapy presumably alters aspects of blood
and cerebrospinal fluid to produce an anticonvulsant effect; in
making and supporting brain slices, it is necessary to replace
blood and cerebrospinal fluid with a bathing solution. Thus,
the major difficulty in using acute hippocampal slices for
ketogenic diet research is the inability to precisely reproduce
or maintain the metabolic condition induced by diet therapy in
this in vitro preparation. The lack of a standard protocol for
a ‘‘diet in a dish’’ is evident in the diversity of experimental
procedures, the prevalence of mixed results and the relative
dearth of studies given the importance of delineating the key
mechanisms underlying an enduring and successful treatment
for a common and challenging neurological condition. In vivo
recording clearly does not have this problem because it uses the
whole body of experimental animals and diet-altered metabolism
is maintained (Koranda et al., 2011; Masino et al., 2011).
Several special strategies have been implemented for examining
mechanisms of the ketogenic diet using hippocampal slice
preparations; we focus on reviewing three of these approaches
(Figures 1–3).
THREE STRATEGIES FOR INVESTIGATING
KETOGENIC DIET MECHANISMS IN
HIPPOCAMPAL SLICES
Direct Application of Ketone Bodies to
Hippocampal Slices From Control Diet-Fed
Rodents
The ketogenic diet was developed to mimic fasting, which
alleviates epileptic seizures (Wilder, 1921). Ketogenic diet feeding
increases ketone bodies (β-hydroxybutyrate (βHB), acetoacetate
(AA), acetone) to usually over 1 mM in blood in humans
(Bergqvist et al., 2005; Than et al., 2005) and rodents (Hartman
et al., 2008; Linard et al., 2010) synthesized from free fatty
acids in the liver (Masino and Rho, 2012) and then used
for energy in the brain instead of glucose (Masino et al.,
2009). Chronic ketosis (increased levels of ketone bodies)
is the eponymous metabolic hallmark of the ketogenic diet.
Therefore, one approach to reproducing a ketogenic diet in a
hippocampal slice is a direct application of ketone bodies to
determine if and how ketone bodies modulate neuronal activity
directly.
In this paradigm, hippocampal slices are taken from control
diet-fed animals and dissolved ketone bodies are applied in
an extracellular solution such as artificial cerebrospinal fluid
(Figure 1). Slice preparation protocols, electrophysiological
recording methods, rodent model (different strains of rats or
mice), and mixtures of ketone bodies can be found among the
laboratories. Not surprisingly, results among the studies were
mixed.
A number of studies found negative results. Thio et al.
(2000) reported that direct application of ketone bodies had
no effect on synaptic activity in acute hippocampal slices from
Sprague-Dawley (SD) rats. They recorded evoked field excitatory
postsynaptic potentials (fEPSP) and population spikes (PS) in
the CA1 region stimulated by Schaffer collateral fibers and
applied mixed ketone bodies (1 mM AA and 2 mM βHB)
to the slices. A 20 min application of ketone bodies did
not change either fEPSP slope or PS amplitude. They also
recorded potassium channel blocker 4-aminopyridine-induced
epileptiform discharges from the dentate granule cell layer and
CA3 region and reported that application for 105 min did
not change the frequency or duration of these ictal events.
Kimura et al. (2012) also reported that application of mixed
ketone bodies (1 mM each AA and βHB) for 20 min did
not change fEPSP slope and an 80 min application did not
change the high-frequency tetanic stimulation-induced long-
term potentiation (LTP) recorded from CA1 region in acute
hippocampal slices from Wistar rats. Similar results were
reported that mixed ketone bodies (1 mM AA and 2 mM βHB)
had no effect on CA1 region synaptic transmission or theta
burst-induced LTP in SD rat acute hippocampal slices (Youssef,
2015). A unique approach was used by Samoilova et al. (2010).
They made organotypic hippocampal slices which were cultured
with low glucose and 10 mM βHB medium for at least 3 days.
This chronic in vitro ketosis, however, did not alleviate intrinsic
or induced epileptiform discharges (but was neuroprotective).
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FIGURE 1 | Direct application of ketone bodies to hippocampal slices From control diet-fed animals. Reference list is shown at bottom. Three of seven
references report positive effects for antiseizure with direct application of ketone bodies. AA, acetoacetate; βHB, β-hydroxybutyrate; fEPSP, field postsynaptic
potential; PS, population spike.
All of these studies concluded that ketone bodies do not directly
affect synaptic transmission, seizure-like activity or LTP in the
rat hippocampal slice.
Other studies, however, have found positive results and
even revealed new mechanisms. Juge et al. (2010) made
acute hippocampal slices from C57BL/6 mice and incubated
the slices with 10 mM AA for over 2 h, after which
they recorded EPSPs from CA1 pyramidal neurons using
whole-cell patch clamp. Frequency and amplitude of miniature
EPSPs (mEPSP) from AA-incubated slices were significantly
reduced compared with control slices. Ketone bodies inhibited
valinomycin-evoked glutamate uptake by the purified vesicular
glutamate transporter (VGLUT), suggesting that ketone bodies
inhibit synaptic transmission with reduction of glutamate
release via direct ketone body-induced suppression of glutamate
uptake into vesicles. Importantly, they also investigated the
behavioral effects of ketone bodies. Seizures in Wistar rats
induced by intrahippocampal 4-aminopyridine were moderated
by intrahippocampal 10 mM AA, both infused by microdialysis.
These results clearly show that direct application of ketone
bodies modulates synaptic transmission in hippocampal slices
and reduces seizure activity in vivo (Juge et al., 2010). In addition,
Tanner et al. (2011) recorded single channel activity from
dentate granule neurons after incubating acute hippocampal
slices from C57BL/6 mice with 2 mM βHB for over 40 min.
Preincubation with this ketone body increased steady-state and
stimulus-elevated open probability of Adenosine triphosphate
(ATP)-sensitive potassium (KATP) channels, which contribute
to the slow afterhyperpolarization after action potential bursts
to modulate spontaneous firing, suggesting that direct ketone
body-mediated opening of KATP channels in dentate granule
neurons may act as a seizure gate in the hippocampus. Similar
results were reported from neurons of the substantia nigra in
coronal midbrain slices of rats and mice from same laboratory
(Ma et al., 2007). Kim et al. (2015) recorded from organotypic
hippocampal slices which were cultured with 5 mM βHB
and 1 mM AA medium for 2 weeks. They used Kcna1-null
mice (C3HeB/FeJ background) lacking voltage-gated potassium
(Kv1.1) channels, which is thought be a model for several types of
epilepsy including human temporal lobe epilepsy. Extracellular
multielectrode array recordings showed spontaneous seizure-like
events in organotypic hippocampal slice cultures from Kcna1-
null mice. The application of ketone bodies for 2 weeks
attenuated the seizure-like events in the mutant tissue. They
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FIGURE 2 | Controlling glucose and adenosine triphosphate (ATP) levels by using whole-cell patch clamp recording of a single cell in a hippocampal
slice from control diet-fed animals. To mimic the ketogenic diet milieu, extracellular glucose is reduced and intracellular ATP is increased. Reference is shown at
bottom. [ATP]i, intracellular ATP concentration; [glucose]e, extracellular glucose concentration.
also applied 5 mM βHB in vivo using subcutaneously implanted
osmotic minipumps to Kcna1-null mice and reported that
administration of this ketone body reduced the number of
seizures (Kim et al., 2015). In typical studies, slice preparations
are maintained by higher extracellular glucose concentration
than is physiological; up to 25–30 mM extracellular glucose
concentration for acute hippocampal slices (Bischofberger et al.,
2006) and 10–12 mM extracellular glucose for hippocampal
slice cultures [Galow et al., 2014; but electrophysiological
recording can be done in 5–10 mM glucose (Schneider et al.,
2015)]. Since it is reported that complete replacement from
glucose to ketone bodies decreases neuronal activity (Arakawa
et al., 1991; Wada et al., 1997), all experiments for direct
application of ketone bodies were done by adding ketone
bodies to the usual in vitro glucose concentration for slice
preparations. Experiments using purified VGLUT by Juge et al.
(2010) were done with glucose-free conditions and the results
showed the direct effect of ketone bodies clearly. Ma et al.
(2007) compared the effect of ketone body application ranging
between 12 mM and 5 mM extracellular glucose concentration
in coronal midbrain slices and found the effect was not
changed by reduced glucose. These reports suggest that the
effects of ketone bodies might not be correlated with glucose
concentration.
In sum, several studies have used direct application of ketone
bodies in hippocampal acute slices or organotypic cultures, and
both positive and negative results have been found. Negative
and positive studies used rats and mice, respectively, so a
simple explanation is that the discrepancy arises from species
differences. This seems unlikely because ketogenic diet is known
to reduce behavioral seizures in both rats (Appleton and DeVivo,
1974; Hori et al., 1997; Bough et al., 2002, 2006; Zhao et al.,
2004), and mice (Uhlemann and Neims, 1972; Rho et al., 1999;
Noh et al., 2003; Hartman et al., 2008; Kwon et al., 2008;
but see Linard et al., 2010). The methods for applying ketone
bodies varied in these reports including concentration of ketone
bodies, time for application and application pathway (perfusion
or preincubation) and these might contribute to inter-study
variation. Aligning technical details for direct application of
ketone bodies may be useful for finding common mechanisms.
Changing Intracellular ATP and
Extracellular Glucose With Whole-Cell
Patch Clamp to Mimic Ketogenic Diet
A less common approach mimics the altered metabolism
found during ketogenic diet treatment using single-cell patch
clamp recording. Fasting and ketogenic diet are thought to
cause anticonvulsant effect by changing brain metabolism,
and this approach attempts to mimic a key metabolic ‘‘end
point.’’ The other metabolic hallmark (besides ketosis) of
the ketogenic diet is a stable, mild hypoglycemia in humans
(Huttenlocher, 1976; Noakes et al., 2006; Nuttall et al.,
2015) and rodents (Bough et al., 2006). It is also reported
that ketogenic diet decreases glucose concentration in the
hippocampal extracellular fluid by 30% compared to control diet
measured by in vivo microdialysis in mice (although lactate did
not change; Samala et al., 2011). Interestingly, plasma glucose
level correlates with the antiepileptic effect of the ketogenic
diet (Mantis et al., 2004), indicating that extracellular glucose
is mechanistically relevant. Intracellular conditions are also
thought to be changed by ketogenic diet-altered metabolism
and product major goal of brain energy metabolism is the
generation of sufficient ATP. Several studies have reported
that ketogenic diet increases brain ATP levels in humans (Pan
et al., 1995) and rodents (DeVivo et al., 1978; Nakazawa
et al., 1983; Nylen et al., 2009), thought to be caused by
mitochondrial biogenesis leading from chronic ketosis (Bough
et al., 2006). Therefore, intracellular ATP is a promising
mechanism for mimicking the ketogenic diet in vitro. From
these reports, reducing and increasing extracellular glucose
and intracellular ATP, respectively, might in combination
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FIGURE 3 | Acute hippocampal slices from ketogenic diet-fed animals. Extracellular glucose is reduced during incubation and recording to maintain the in vivo
effect of the ketogenic diet. Reference list is shown at bottom. fEPSP, field postsynaptic potential; PS, population spike. Ketogenic diet (4.8:1) or (6:1) means fat:
[protein + carbohydrate] ratio.
reproduce ketogenic diet conditions in acute hippocampal slices
(Figure 2). As mentioned in ‘‘Advantages of the Hippocampal
Slice Preparation in Studying Antiepileptic Mechanisms of
Ketogenic Diet’’ Section, it is easy to change extracellular
solution with an in vitro brain slice (including moderately
lowering glucose), but trickier to change the intracellular milieu.
The whole-cell patch clamp technique is one of the methods
for recording a single cell (Kawamura et al., 2004). This
technique allows physical exchange between the intracellular
fluid and the artificial intracellular solution in the recording
pipette, enabling experimental modification of the intracellular
fluid of the recorded neuron (Figure 2) including elevating
intracellular ATP. We recorded from CA3 pyramidal neurons
with the whole-cell patch clamp technique in acute hippocampal
slices from control diet-fed SD rats or C57BL/6 mice. We
found that increased intracellular ATP (comparing 0.5, 1,
2 and 5 mM ATP concentration in the intracellular solutions)
and reduced extracellular glucose (from 11 mM to 3 mM)
caused an outward current (hyperpolarization when recording
membrane potential) in CA3 pyramidal neurons (Kawamura
et al., 2010). The direction and magnitude of this current was
dose-dependent for both extracellular glucose and intracellular
ATP, and importantly it was found in both rats and mice.
Pharmacological and genetic experiments demonstrated that
when intracellular ATP was sufficient or increased, reducing
extracellular glucose opened pannexin-1 channels and released
intracellular ATP to the extracellular space. Released ATP was
rapidly hydrolyzed to adenosine which activated adenosine A1
receptors (A1R) with subsequent opening of KATP channels.
Opening of these potassium channels caused hyperpolarization
and reduced excitability. These results indicate that mimicking
the ketogenic diet condition with increased ATP and reduced
glucose reduces excitability in hippocampal CA3 pyramidal
neurons with autocrine modulation via adenosine A1R, and this
might be a one of the key mechanisms of the anticonvulsant
effects of the ketogenic diet in vivo (Figure 4). This approach
for reproducing ketogenic diet conditions in acute hippocampal
slice is useful to elucidate detailed mechanisms within single
neurons. However, it mimics only two of the aspects of ketogenic
diet feeding. Further examinations using behavioral tests and
recordings from in vivo ketogenic diet-fed animals are needed to
link the results from this approach to the effects of ketogenic diet
feeding.
Hippocampal Slices From Ketogenic
Diet-Fed Rodents
A third approach is possibly the most direct and useful way for
investigating mechanisms of ketogenic diet because it uses acute
hippocampal slices from ketogenic diet-fed animals (Figure 3).
In patients, ketogenic diet is applied through three meals with
snacks and the typical fat: (protein+carbohydrate) ratio is 3:1 or
4:1 in children (Hartman and Vining, 2007; Zupec-Kania and
Spellman, 2008) and down to 1:1 in adults. On the other hand
ketogenic diet for rodents is usually applied by free access to
food with more strict ketogenic ratio 4.8:1 or 6:1 (da Silveira
et al., 2010). One question about this approach is whether or not
the intra- and extracellular milieu produced by ketogenic diet
feeding can be maintained after making and incubating brain
slices. However, four reports show that it can work successfully.
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FIGURE 4 | Schematic of pannexin-1 channel-adenosine A1
receptor-KATP channel autocrine regulation in CA3 pyramidal neurons
and relationship to ketogenic diet. Ketogenic diet-fed animal increases
ketone body levels and reduces glucose levels. Ketone bodies might increase
intracellular ATP concentration, and increased ATP is released to the
extracellular space through reduced glucose-induced opening of pannexin-1
channels (panx). After breakdown to adenosine by nucleotidases, activated
adenosine A1 receptors (A1R) open ATP-sensitive potassium (KATP) channels
which hyperpolarizes CA3 pyramidal neurons. This hyperpolarization reduces
neuronal hyperexcitability and causes the ketogenic diet’s antiseizure effects.
Stafstrom et al. (1999) reported that a ketogenic diet (4.8:1 ratio)
induced antiseizure effects in acute hippocampal slices from
kainic acid-treated rats. They recorded fEPSP and PS from
area CA1 from SD rats fed a ketogenic diet for 6–8 weeks.
Synaptic transmission was not significantly different between
slices from control diet-fed and ketogenic diet-fed rats. However
the frequency of kainic acid-induced spontaneous seizures was
significantly lower in slices from ketogenic diet-fed rats than
from control diet-fed rats. The slices were incubated by normal
artificial cerebrospinal fluid not including ketone bodies. The
authors concluded that the effects observed in the slices from
ketogenic diet-fed rats would be independent of direct ketone
body action (Stafstrom et al., 1999). Similar results were reported
by Simeone et al. (2014) using extracellular multielectrode
array recordings in acute hippocampal slices from ketogenic
diet-fed Knca1-null mice. The pathologic seizure-like events
generated in Knca1-null mice slice were diminished by ketogenic
diet (6:1 ratio) treatment for 11–15 days. Mossy fiber-CA3
dendritic field potential slopes and fiber volley amplitudes of
mossy fiber were not significantly different between slices from
control diet-fed and ketogenic diet-fedKnca1-null mice, however
ketogenic diet increased paired-pulse facilitation ratios and the
half maximal stimulation intensities of field potential slope
which are decreased by Kv1.1 knock out. They suggested that
the improvement of mitochondria function by ketogenic diet
might restore the hyperexcitability of CA3 neurons in Knca1-
null mice and decrease seizure-like events (Simeone et al., 2014).
Bough et al. (2006) recorded medial perforant pathway-evoked
fEPSPs from the dentate molecular layer in acute hippocampal
slices from SD rats fed with a ketogenic diet (6:1 ratio) for
over 20 days. Reducing extracellular glucose concentration
from 10 to 2 mM depressed the slope of fEPSP reversibly
in slices from control diet-fed rats and this depression was
inhibited in slice from ketogenic diet-fed rats. The effects were
lost after slices were incubated in 10 mM glucose for over
3.5 h. This result, however, strongly suggests that intracellular
metabolic changes with ketogenic diet can be maintained
over 3 h after changing extracellular conditions into artificial
cerebrospinal fluid. They concluded that synaptic transmissions
in hippocampal slices from ketogenic diet-fed rats were more
resistant to reduced glucose than slices from control diet-fed
rats with facilitation of mitochondrial biogenesis (Bough et al.,
2006). We also reported that ketogenic diet caused antiseizure
effects in acute hippocampal slices of rats and mice (Kawamura
et al., 2014). We recorded PS and GABA receptor blocker
bicuculline-induced seizure-like bursting from the CA3 region
in acute hippocampal slices from SD rats or C57BL/6 mice
fed a ketogenic diet (6:1 ratio) for 13–18 days. Excitability
and bicuculline-induced bursting were significantly inhibited
by reduced extracellular glucose concentration in slices from
ketogenic diet-fed rats andmice but were not changed by reduced
extracellular glucose in slices from control diet-fed rodents. In
this study, the effect of ketogenic diet feeding is maintained
for at least 6 h after making hippocampal slices. Ketogenic
diet-induced suppression of bicuculline-induced bursting was
inhibited by adenosine A1R antagonist and did not occur in
slices from adenosine A1R knock-out mice. Antagonism of
KATP channels or pannexin-1 channels inhibited the ketogenic
diet-induced suppression of bicuculline-induced bursting. These
results suggest that ketogenic diet causes antiseizure effects
through a pannexin-1 channel-adenosine A1R-KATP channel
autocrine pathway (Figure 4), the same pathway revealed by
the whole-cell patch clamp technique for mimicking ketogenic
diet conditions as described in ‘‘Changing Intracellular ATP and
Extracellular Glucose with Whole-Cell Patch Clamp to Mimic
Ketogenic Diet’’ Section (Kawamura et al., 2010).
These studies used acute hippocampal slices from ketogenic
diet-fed rodents successfully to elucidate altered neuronal activity
underlying this treatment. Interestingly, reducing extracellular
glucose concentration is thought be one of the most important
points for reproducing the effects of ketogenic diet in this
approach. Synaptic transmission in hippocampal slices from
ketogenic diet-fed rodents were not different from slices
from control diet-fed rodents when extracellular glucose
concentration in artificial cerebrospinal fluid is standard in all
three reports [however, evidence is mounting that this standard
glucose concentration for acute brain slices is higher than
physiological brain glucose levels (Shram et al., 1997; Lowry and
Fillenz, 2001; Kealy et al., 2013)]. Reduced glucose reveals the
difference between ketogenic diet- and control diet-fed animals
in two of these studies (Bough et al., 2006; Kawamura et al., 2014),
which parallels the finding that the anticonvulsant effect of the
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 Novemeber 2016 | Volume 9 | Article 112
Kawamura Jr. et al. Metabolic Therapy in a Dish
ketogenic diet is correlated with plasma glucose levels (Mantis
et al., 2004). Therefore it would be useful to make extracellular
glucose concentrations lower than standard to reproduce or
maintain effects of the ketogenic diet in acute hippocampal slices.
CONCLUSION
Here we describe three approaches for researching
anticonvulsant mechanisms of ketogenic diets by using
electrophysiological recording from hippocampal slices.
The usefulness of hippocampal slices is that it is easy to
elucidate the details of neuronal modulation by ketogenic diet
as shown in Figure 4. All three approaches have contributed
to finding detailed potential mechanisms underlying ketogenic
diet effects including VGLUT modulation, KATP opening,
activation of adenosine receptors, and ATP release from
pannexin channels. Complementary in vivo work has provided
additional evidence for some of these mechanisms (Masino
et al., 2011; Giménez-Cassina et al., 2012). Taken together, it
is clear that electrophysiological recordings from hippocampal
slices is a good tool for ketogenic diet research. However,
all three approaches need experimental manipulations for
reproducing ketogenic diet effects in vitro such as ketone
application, reduced extracellular glucose and increased
intracellular ATP, and this requirement may explain the lack
of a standardized protocol and a robust literature in this area.
Finally, electrophysiology in slices is not a direct measurement
of the in vivo anticonvulsant effects of ketogenic diet, and a
combination of both in vivo and in vitro recordings is the best
approach to provide further insight into the key anticonvulsant
mechanisms underlying ketogenic diet and other metabolic
therapies.
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